Northstar Asset Management Inc. Reduces Holdings in Danaher Corporation $DHR

Northstar Asset Management Inc. decreased its position in Danaher Corporation (NYSE:DHR) by 0.6% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 32,319 shares of the conglomerate’s stock after selling 209 shares during the period. Danaher accounts for approximately 1.8% of Northstar Asset Management Inc.’s investment portfolio, making the stock its 24th largest position. Northstar Asset Management Inc.’s holdings in Danaher were worth $6,384,000 at the end of the most recent quarter.

Several other hedge funds have also made changes to their positions in DHR. Nuveen LLC purchased a new stake in shares of Danaher in the 1st quarter valued at approximately $833,941,000. Invesco Ltd. boosted its position in shares of Danaher by 44.5% during the 1st quarter. Invesco Ltd. now owns 4,708,578 shares of the conglomerate’s stock worth $965,259,000 after purchasing an additional 1,450,703 shares during the period. Baird Financial Group Inc. boosted its position in shares of Danaher by 290.6% during the 1st quarter. Baird Financial Group Inc. now owns 1,441,706 shares of the conglomerate’s stock worth $295,550,000 after purchasing an additional 1,072,617 shares during the period. Generation Investment Management LLP boosted its position in shares of Danaher by 33.2% during the 1st quarter. Generation Investment Management LLP now owns 3,178,124 shares of the conglomerate’s stock worth $651,515,000 after purchasing an additional 791,662 shares during the period. Finally, Parnassus Investments LLC boosted its position in shares of Danaher by 23.3% during the 1st quarter. Parnassus Investments LLC now owns 3,828,024 shares of the conglomerate’s stock worth $784,745,000 after purchasing an additional 722,636 shares during the period. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on the stock. JPMorgan Chase & Co. increased their price objective on shares of Danaher from $260.00 to $270.00 and gave the stock an “overweight” rating in a research report on Wednesday. UBS Group reduced their target price on shares of Danaher from $240.00 to $225.00 and set a “buy” rating on the stock in a report on Wednesday, July 23rd. Wells Fargo & Company reiterated a “positive” rating on shares of Danaher in a report on Thursday. Cowen reiterated a “buy” rating on shares of Danaher in a report on Wednesday. Finally, Bank of America reduced their target price on shares of Danaher from $230.00 to $220.00 and set a “buy” rating on the stock in a report on Monday, September 22nd. Eighteen investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $243.39.

Danaher Price Performance

Shares of DHR opened at $223.03 on Friday. The firm’s fifty day simple moving average is $202.73 and its 200-day simple moving average is $198.36. Danaher Corporation has a twelve month low of $171.00 and a twelve month high of $258.23. The company has a current ratio of 1.52, a quick ratio of 1.22 and a debt-to-equity ratio of 0.33. The firm has a market capitalization of $157.54 billion, a price-to-earnings ratio of 45.99, a PEG ratio of 3.41 and a beta of 0.77.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Tuesday, October 21st. The conglomerate reported $1.89 EPS for the quarter, topping the consensus estimate of $1.72 by $0.17. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The firm had revenue of $6.05 billion for the quarter, compared to analyst estimates of $6 billion. During the same period last year, the business earned $1.71 EPS. Danaher’s revenue for the quarter was up 4.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Equities analysts forecast that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be given a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.6%. The ex-dividend date of this dividend is Friday, September 26th. Danaher’s dividend payout ratio (DPR) is presently 26.39%.

Insider Transactions at Danaher

In other Danaher news, Director Teri List sold 2,778 shares of the firm’s stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the transaction, the director directly owned 20,751 shares of the company’s stock, valued at approximately $4,379,706.06. This trade represents a 11.81% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders own 11.10% of the company’s stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.